Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04553692
Title Study of IGM-8444 as a Single Agent and in Combination With Chemotherapy-based Regimens in Subjects With Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors IGM Biosciences, Inc.

Advanced Solid Tumor


Bevacizumab + Fluorouracil + IGM-8444 + Irinotecan + Leucovorin

Fluorouracil + IGM-8444 + Irinotecan + Leucovorin


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.